Table 1.
Baseline Clinical Characteristics According to Presence or Absence of Clinical Events
| Variables | All Patients n=278 | No Events n=131 (47%) | Events n=147 (53%) | P Value |
|---|---|---|---|---|
| Age, y | 65.0±15.1 | 62.6±15.8 | 67.1±14.2 | 0.02 |
| Male sex | 160 (58) | 65 (50) | 95 (65) | 0.01 |
| BMI, kg/m² | 23.5±3.6 | 23.4±3.6 | 23.7±3.8 | 0.44 |
| Risk factors | ||||
| Hypertension | 143 (53) | 62 (47) | 81 (55) | 0.25 |
| Diabetes mellitus | 20 (7) | 7 (5) | 13 (9) | 0.28 |
| Obesity | 12 (4) | 6 (5) | 6 (4) | 0.84 |
| Dyslipidemia | 101 (38) | 43 (33) | 58 (39) | 0.28 |
| Current smoking | 28 (11) | 10 (8) | 18 (12) | 0.19 |
| History of smoking | 84 (33) | 39 (30) | 45 (31) | 0.88 |
| Coronary artery disease | 70 (28) | 20 (18) | 50 (36) | 0.001 |
| Atrial fibrillation | 60 (22) | 23 (18) | 37 (25) | 0.13 |
| Charlson probability | 0.56±0.35 | 0.62±0.32 | 0.50±0.36 | 0.02 |
| Medications | ||||
| Statins | 88 (33) | 41 (31) | 47 (32) | 0.92 |
| ACEI | 87 (32) | 28 (22) | 59 (42) | 0.007 |
| ARB | 49 (18) | 25 (19) | 24 (16) | 0.56 |
| β‐blockers | 71 (26) | 30 (23) | 41 (28) | 0.36 |
| Diuretics | 82 (30) | 35 (27) | 47 (32) | 0.32 |
| Nitrates | 23 (9) | 9 (7) | 14 (10) | 0.41 |
| Follow‐up time | 5.4±3.2 | 7.1±2.7 | 3.9±2.8 | <0.0001 |
Values are expressed as mean±SD or n (%). ACE indicates angiotensin‐converting enzyme inhibitors; ARB, angiotensin receptor blockers; BMI, body mass index.